HU227742B1
(en)
|
1996-10-18 |
2012-02-28 |
Vertex Pharma |
Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease
|
DE60136620D1
(de)
*
|
2000-04-13 |
2009-01-02 |
Pharmasset Inc |
3 oder 2 hydroxymethyl substituierte nucleoside derivate und ihre verwendung zur behandlung von virusinfektionen
|
MY164523A
(en)
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
CZ301182B6
(cs)
|
2000-05-26 |
2009-12-02 |
Idenix (Cayman) Limited |
Použití nukleosidových derivátu pro výrobu farmaceutických prostredku pro lécení infekcí vyvolaných flaviviry a pestiviry
|
SV2003000617A
(es)
|
2000-08-31 |
2003-01-13 |
Lilly Co Eli |
Inhibidores de la proteasa peptidomimetica ref. x-14912m
|
US8481712B2
(en)
*
|
2001-01-22 |
2013-07-09 |
Merck Sharp & Dohme Corp. |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
ES2532836T3
(es)
*
|
2001-01-22 |
2015-04-01 |
Merck Sharp & Dohme Corp. |
Derivados de nucleósidos como inhibidores de la ARN polimerasa viral dependiente de ARN
|
EP2050822B1
(fr)
|
2001-01-23 |
2013-07-31 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Réplicons de virus de l'hépatite C et cellules améliorées de réplicon
|
US6905669B2
(en)
|
2001-04-24 |
2005-06-14 |
Supergen, Inc. |
Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylase
|
GB0114286D0
(en)
|
2001-06-12 |
2001-08-01 |
Hoffmann La Roche |
Nucleoside Derivatives
|
AU2002330154A1
(en)
*
|
2001-09-28 |
2003-04-07 |
Centre National De La Recherche Scientifique |
Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides
|
AU2002353164A1
(en)
*
|
2001-12-17 |
2003-06-30 |
Ribapharm Inc. |
Unusual nucleoside libraries, compounds, and preferred uses as antiviral and anticancer agents
|
WO2003062256A1
(fr)
*
|
2002-01-17 |
2003-07-31 |
Ribapharm Inc. |
Analogues d'adenosine 2'-beta-modifiee-6-substituee et leur utilisation en tant qu'agents antiviraux
|
AU2002341942A1
(en)
*
|
2002-01-17 |
2003-09-02 |
Ribapharm Inc. |
Sugar modified nucleosides as viral replication inhibitors
|
US7323453B2
(en)
|
2002-02-13 |
2008-01-29 |
Merck & Co., Inc. |
Methods of inhibiting orthopoxvirus replication with nucleoside compounds
|
CA2481502A1
(fr)
*
|
2002-04-04 |
2003-10-16 |
Achillion Pharmaceuticals, Inc. |
Dosage pour evaluer l'activite de composes contre le virus de l'hepatite c par utilisation d'un nouveau systeme de detection dans le replicon du virus de l'hepatite c
|
CN1329407C
(zh)
*
|
2002-04-12 |
2007-08-01 |
阿奇林医药品公司 |
合成β-L-5-氟-2′,3′-双脱氧-2′,3′-双脱氢胞嘧啶核苷的方法
|
CA2481285A1
(fr)
|
2002-04-26 |
2003-11-06 |
Gilead Sciences, Inc. |
Inhibiteurs non nucleosidiques de la transcriptase inverse
|
US7247621B2
(en)
|
2002-04-30 |
2007-07-24 |
Valeant Research & Development |
Antiviral phosphonate compounds and methods therefor
|
WO2003093290A2
(fr)
*
|
2002-05-06 |
2003-11-13 |
Genelabs Technologies, Inc. |
Derives nucleosidiques destines au traitement de l'infection par le virus de l'hepatite c
|
US6982253B2
(en)
|
2002-06-05 |
2006-01-03 |
Supergen, Inc. |
Liquid formulation of decitabine and use of the same
|
AU2003269890A1
(en)
*
|
2002-06-21 |
2004-01-06 |
Isis Pharmaceuticals, Inc. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
CA2488484A1
(fr)
*
|
2002-06-27 |
2004-01-08 |
Merck & Co., Inc. |
Derives nucleosidiques utilises comme inhibiteurs de l'arn polymerase arn-dependante virale
|
AU2003248748A1
(en)
|
2002-06-28 |
2004-01-19 |
Idenix (Cayman) Limited |
2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
|
ES2469569T3
(es)
|
2002-06-28 |
2014-06-18 |
Idenix Pharmaceuticals, Inc. |
Prof�rmacos de nucle�sidos modificados en 2' y 3' para el tratamiento de infecciones de Flaviviridae
|
NZ537662A
(en)
|
2002-06-28 |
2007-10-26 |
Idenix Cayman Ltd |
2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
|
US7608600B2
(en)
*
|
2002-06-28 |
2009-10-27 |
Idenix Pharmaceuticals, Inc. |
Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
|
GB0215293D0
(en)
|
2002-07-03 |
2002-08-14 |
Rega Foundation |
Viral inhibitors
|
US20060264389A1
(en)
*
|
2002-07-16 |
2006-11-23 |
Balkrishen Bhat |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
WO2004009020A2
(fr)
|
2002-07-24 |
2004-01-29 |
Merck & Co., Inc. |
Derives de thionucleosides utilises comme inhibiteurs de l'arn-polymerase arn-dependante virale
|
CA2492607A1
(fr)
*
|
2002-07-25 |
2004-02-05 |
Micrologix Biotech Inc. |
Nucleosides d de 7-deaza antiviraux et leurs utilisations
|
CA2493949C
(fr)
*
|
2002-07-26 |
2015-06-02 |
Chiron Corporation |
Petites molecules modifiees d'arn d'interference et leurs procedes d'utilisation
|
US20040067877A1
(en)
*
|
2002-08-01 |
2004-04-08 |
Schinazi Raymond F. |
2', 3'-Dideoxynucleoside analogues for the treatment or prevention of Flaviviridae infections
|
AU2003257157C1
(en)
*
|
2002-08-01 |
2010-03-18 |
Pharmasset Inc. |
Compounds with the bicyclo[4.2.1] nonane system for the treatment of Flaviviridae infections
|
DE10238722A1
(de)
|
2002-08-23 |
2004-03-11 |
Bayer Ag |
Selektive Phosphodiesterase 9A-Inhibitoren als Arzneimittel zur Verbesserung kognitiver Prozesse
|
PL376043A1
(en)
|
2002-09-30 |
2005-12-12 |
Genelabs Technologies, Inc. |
Nucleoside derivatives for treating hepatitis c virus infection
|
US7094768B2
(en)
|
2002-09-30 |
2006-08-22 |
Genelabs Technologies, Inc. |
Nucleoside derivatives for treating hepatitis C virus infection
|
US20050075279A1
(en)
|
2002-10-25 |
2005-04-07 |
Boehringer Ingelheim International Gmbh |
Macrocyclic peptides active against the hepatitis C virus
|
BR0315806A
(pt)
*
|
2002-10-31 |
2005-09-13 |
Metabasis Therapeutics Inc |
Fosfato diésteres cìclicos de 1,3-propano-1-aril diós e seu uso na preparação de pró-drogas
|
HUE033832T2
(en)
|
2002-11-15 |
2018-01-29 |
Idenix Pharmaceuticals Llc |
2'-methyl nucleosides in combination with interferon and Flaviviridae mutation
|
US7034167B2
(en)
|
2002-12-06 |
2006-04-25 |
Merck & Co., Inc. |
Process to ribofuranose sugar derivatives as intermediates to branched-chain nucleosides
|
JP5116972B2
(ja)
|
2002-12-12 |
2013-01-09 |
イデニクス(ケイマン)リミテツド |
2’−分枝ヌクレオシドの製造方法
|
MXPA05006865A
(es)
*
|
2002-12-23 |
2005-12-12 |
Idenix Cayman Ltd |
Proceso para la produccion de profarmacos 3'-nucleosidos.
|
CA2511521C
(fr)
|
2002-12-30 |
2012-02-07 |
Angiotech International Ag |
Liberation de medicaments a partir d'une composition polymere a gelification rapide
|
US7223785B2
(en)
|
2003-01-22 |
2007-05-29 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
AR043006A1
(es)
|
2003-02-12 |
2005-07-13 |
Merck & Co Inc |
Proceso para preparar ribonucleosidos ramificados
|
EP1626692A4
(fr)
*
|
2003-03-28 |
2008-12-10 |
Pharmasset Inc |
Composes permettant de traiter les infections par flavivirus
|
GB0307891D0
(en)
*
|
2003-04-04 |
2003-05-14 |
Angeletti P Ist Richerche Bio |
Chemical compounds,compositions and uses
|
US7470724B2
(en)
|
2003-04-25 |
2008-12-30 |
Gilead Sciences, Inc. |
Phosphonate compounds having immuno-modulatory activity
|
US7432261B2
(en)
|
2003-04-25 |
2008-10-07 |
Gilead Sciences, Inc. |
Anti-inflammatory phosphonate compounds
|
US7452901B2
(en)
|
2003-04-25 |
2008-11-18 |
Gilead Sciences, Inc. |
Anti-cancer phosphonate analogs
|
US7407965B2
(en)
|
2003-04-25 |
2008-08-05 |
Gilead Sciences, Inc. |
Phosphonate analogs for treating metabolic diseases
|
WO2005002626A2
(fr)
*
|
2003-04-25 |
2005-01-13 |
Gilead Sciences, Inc. |
Composes de phosphonate therapeutiques
|
US7427636B2
(en)
|
2003-04-25 |
2008-09-23 |
Gilead Sciences, Inc. |
Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
|
US7417055B2
(en)
|
2003-04-25 |
2008-08-26 |
Gilead Sciences, Inc. |
Kinase inhibitory phosphonate analogs
|
MXPA05011297A
(es)
*
|
2003-04-25 |
2006-05-25 |
Gilead Sciences Inc |
Analogos antivirales de fosfonato.
|
US7300924B2
(en)
|
2003-04-25 |
2007-11-27 |
Gilead Sciences, Inc. |
Anti-infective phosphonate analogs
|
US20040259934A1
(en)
*
|
2003-05-01 |
2004-12-23 |
Olsen David B. |
Inhibiting Coronaviridae viral replication and treating Coronaviridae viral infection with nucleoside compounds
|
EP3521297B1
(fr)
|
2003-05-30 |
2021-12-22 |
Gilead Pharmasset LLC |
Analogues de nucléoside fluorés modifiés
|
US7304085B2
(en)
|
2003-06-04 |
2007-12-04 |
Genelabs Technologies, Inc. |
Nitrogen-containing heteroaryl derivatives
|
US7429596B2
(en)
*
|
2003-06-20 |
2008-09-30 |
The Regents Of The University Of California |
1H-pyrrolo [2,3-D] pyrimidine derivatives and methods of use thereof
|
US7572581B2
(en)
|
2003-06-30 |
2009-08-11 |
Roche Molecular Systems, Inc. |
2′-terminator nucleotide-related methods and systems
|
US7947817B2
(en)
|
2003-06-30 |
2011-05-24 |
Roche Molecular Systems, Inc. |
Synthesis and compositions of 2'-terminator nucleotides
|
JP2007527396A
(ja)
*
|
2003-06-30 |
2007-09-27 |
イデニクス(ケイマン)リミテツド |
β−L−2’−デオキシヌクレオシドの合成
|
EP1658302B1
(fr)
*
|
2003-07-25 |
2010-08-25 |
IDENIX Pharmaceuticals, Inc. |
Analogues des nucleosides puriques pour traiter flaviviridae et notamment l'hepatite c
|
WO2005012288A1
(fr)
|
2003-08-01 |
2005-02-10 |
Genelabs Technologies, Inc |
Derives de l'imidazole bicycliques diriges contre les flaviviridae
|
WO2005018330A1
(fr)
*
|
2003-08-18 |
2005-03-03 |
Pharmasset, Inc. |
Regime de dosage pour therapie contre flaviviridae
|
WO2005021568A2
(fr)
|
2003-08-27 |
2005-03-10 |
Biota, Inc. |
Nouveau nucleosides ou nucleotides tricycliques utillises comme agents therapeutiques
|
AR045596A1
(es)
|
2003-09-05 |
2005-11-02 |
Vertex Pharma |
Inhibidores de proteasas de serina en particular proteasa ns3-ns4a del vhc
|
MXPA06003963A
(es)
|
2003-10-14 |
2006-08-25 |
Intermune Inc |
Acidos carboxilicos macrociclicos y acilsulfonamidas como inhibidores de replicacion del hcv.
|
US7144868B2
(en)
|
2003-10-27 |
2006-12-05 |
Genelabs Technologies, Inc. |
Nucleoside compounds for treating viral infections
|
US7427624B2
(en)
|
2003-10-24 |
2008-09-23 |
Gilead Sciences, Inc. |
Purine nucleoside phosphorylase inhibitory phosphonate compounds
|
WO2005042773A1
(fr)
|
2003-10-24 |
2005-05-12 |
Gilead Sciences, Inc. |
Procedes et compositions permettant d'identifier des composes therapeutiques
|
US7432273B2
(en)
|
2003-10-24 |
2008-10-07 |
Gilead Sciences, Inc. |
Phosphonate analogs of antimetabolites
|
US7202223B2
(en)
*
|
2003-10-27 |
2007-04-10 |
Genelabs Technologies, Inc. |
Nucleoside compounds for treating viral infections
|
NZ546201A
(en)
*
|
2003-10-27 |
2009-05-31 |
Genelabs Tech Inc |
Nucleoside compounds for treating viral infections
|
MXPA06004680A
(es)
*
|
2003-10-27 |
2007-04-17 |
Genelabs Tech Inc |
Compuestos de nucleosido para el tratamiento de infecciones virales.
|
WO2005044835A1
(fr)
|
2003-10-27 |
2005-05-19 |
Genelabs Technologies, Inc. |
Procedes de preparation de derives 7-(2'-$g(b)-d-ribofuranosyl substitue)-4-(nr2r3)-5-(ethyn-1-yl substitue)-pyrrolo[2,3-d]pyrimidine
|
US20080287471A1
(en)
|
2003-12-22 |
2008-11-20 |
Maria Fardis |
4'-Substituted Carbovir And Abacavir-Derivatives As Well As Related Compounds With Hiv And Hcv Antiviral Activity
|
US20070258946A1
(en)
*
|
2003-12-23 |
2007-11-08 |
Blatt Lawrence M |
Combination Therapy for Treating Hepatitis C Virus Infection
|
WO2005062949A2
(fr)
*
|
2003-12-23 |
2005-07-14 |
Intermune, Inc. |
Methode permettant de traiter l'infection par un hepatovirus
|
GB0500020D0
(en)
|
2005-01-04 |
2005-02-09 |
Novartis Ag |
Organic compounds
|
EP1730167B1
(fr)
|
2004-01-21 |
2011-01-12 |
Boehringer Ingelheim International GmbH |
Peptides macrocycliques actifs contre le virus de l'hepatite c
|
US20050182252A1
(en)
|
2004-02-13 |
2005-08-18 |
Reddy K. R. |
Novel 2'-C-methyl nucleoside derivatives
|
EA013207B1
(ru)
|
2004-02-20 |
2010-04-30 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Ингибиторы вирусной полимеразы
|
WO2005107742A1
(fr)
|
2004-05-05 |
2005-11-17 |
Yale University |
Nouveaux analogues antiviraux de l'helioxanthine
|
EP1758453B1
(fr)
|
2004-06-15 |
2014-07-16 |
Merck Sharp & Dohme Corp. |
Analogues nucleosidiques de c-purine, servant d'inhibiteurs d'arn-polymerase virale arn-dependante
|
CA2571675A1
(fr)
*
|
2004-06-23 |
2006-01-05 |
Idenix (Cayman) Limited |
Derives de 5-aza-7-deazapurine pour le traitement des infections avec flaviviridae
|
EP1773355B1
(fr)
*
|
2004-06-24 |
2014-06-25 |
Merck Sharp & Dohme Corp. |
Phosphoramidates d'aryle nucleosidiques pour le traitement d'infection virale arn dependante de l'arn
|
US7745125B2
(en)
|
2004-06-28 |
2010-06-29 |
Roche Molecular Systems, Inc. |
2′-terminator related pyrophosphorolysis activated polymerization
|
JP4283738B2
(ja)
*
|
2004-07-08 |
2009-06-24 |
浜松ホトニクス株式会社 |
半導体レーザ装置
|
ATE543789T1
(de)
*
|
2004-07-21 |
2012-02-15 |
Pharmasset Inc |
Herstellung von alkylsubstituierten 2-desoxy-2- fluor-d-ribofuranosylpyrimidinen und -purinen und derivaten davon
|
CN101023094B
(zh)
|
2004-07-21 |
2011-05-18 |
法莫赛特股份有限公司 |
烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
|
UA88313C2
(ru)
|
2004-07-27 |
2009-10-12 |
Гилиад Сайенсиз, Инк. |
Фосфонатные аналоги соединений ингибиторов вич
|
US7597884B2
(en)
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
JP2006077004A
(ja)
*
|
2004-08-11 |
2006-03-23 |
Chugai Pharmaceut Co Ltd |
抗hcv作用を有する化合物およびそれを含む医薬組成物
|
WO2006021341A1
(fr)
*
|
2004-08-23 |
2006-03-02 |
F. Hoffmann-La Roche Ag |
4’-azido-nucléosides antiviraux
|
RU2433124C2
(ru)
|
2004-09-14 |
2011-11-10 |
Фармассет, Инк. |
Способ получения 2'-фтор-2'-алкилзамещенных или других замещенных рибофуранозилпиримидинов и пуринов и их производных
|
WO2006039488A2
(fr)
*
|
2004-10-01 |
2006-04-13 |
Vertex Pharmaceuticals Incorporated |
Inhibition de la protease ns3-ns4a du vhc
|
JP2008517912A
(ja)
*
|
2004-10-21 |
2008-05-29 |
メルク エンド カムパニー インコーポレーテッド |
RNA依存性RNAウイルス感染治療用フッ素化ピロロ[2,3−d]ピリミジンヌクレオシド
|
TW201424733A
(zh)
|
2004-10-29 |
2014-07-01 |
Vertex Pharma |
劑量型式
|
CN101166750A
(zh)
|
2004-10-29 |
2008-04-23 |
拜奥克里斯特制药公司 |
治疗用呋喃并嘧啶类化合物和噻吩并嘧啶类化合物
|
US9512125B2
(en)
|
2004-11-19 |
2016-12-06 |
The Regents Of The University Of California |
Substituted pyrazolo[3.4-D] pyrimidines as anti-inflammatory agents
|
WO2006121468A1
(fr)
*
|
2004-11-22 |
2006-11-16 |
Genelabs Technologies, Inc. |
Composes 5-nitro-nucleoside pour le traitement des infections virales
|
JP2008531704A
(ja)
|
2005-02-28 |
2008-08-14 |
ジェネラブズ テクノロジーズ インコーポレーティッド |
ウイルス感染症の治療のための三環式ヌクレオシド化合物
|
US7524831B2
(en)
|
2005-03-02 |
2009-04-28 |
Schering Corporation |
Treatments for Flaviviridae virus infection
|
AU2006222563A1
(en)
|
2005-03-08 |
2006-09-14 |
Biota Scientific Management Pty Ltd. |
Bicyclic nucleosides and nucleotides as therapeutic agents
|
JP2008535932A
(ja)
*
|
2005-03-09 |
2008-09-04 |
イデニクス(ケイマン)リミテツド |
抗ウィルス剤としての非天然塩基を有するヌクレオシド
|
JP4516863B2
(ja)
*
|
2005-03-11 |
2010-08-04 |
株式会社ケンウッド |
音声合成装置、音声合成方法及びプログラム
|
US7250416B2
(en)
|
2005-03-11 |
2007-07-31 |
Supergen, Inc. |
Azacytosine analogs and derivatives
|
WO2008147454A1
(fr)
*
|
2006-11-16 |
2008-12-04 |
Case Western Reserve University |
Inhibiteurs sélectifs de la réplication d'adn de translésion
|
WO2006101911A1
(fr)
|
2005-03-16 |
2006-09-28 |
Case Western Reserve University |
Inhibiteurs selectifs de la replication d'adn de translesion
|
WO2007084157A2
(fr)
*
|
2005-03-23 |
2007-07-26 |
Genelabs Technologies, Inc. |
Promédicaments nucléosidiques pour le traitement d'infections virales
|
WO2006102594A1
(fr)
*
|
2005-03-23 |
2006-09-28 |
Genelabs Technologies, Inc. |
Promedicament nucleoside pour le traitement des infections virales
|
CA2602533A1
(fr)
*
|
2005-03-29 |
2006-10-05 |
Biocryst Pharmaceuticals, Inc. |
Therapies contre l'hepatite c
|
WO2006130217A2
(fr)
*
|
2005-04-01 |
2006-12-07 |
The Regents Of The University Of California |
Esters de phosphate de phosphonates de nucleosides substitues
|
TW200720285A
(en)
*
|
2005-04-25 |
2007-06-01 |
Genelabs Tech Inc |
Nucleoside compounds for treating viral infections
|
WO2006119061A2
(fr)
*
|
2005-05-02 |
2006-11-09 |
Merck & Co., Inc. |
Inhibiteurs de la protease ns3 du vhc
|
WO2006122207A1
(fr)
*
|
2005-05-10 |
2006-11-16 |
Valeant Research & Development |
6-hydrazinopurine 2'-methyl ribonucleosides et nucleotides pour le traitement de hcv
|
NZ563909A
(en)
|
2005-05-13 |
2011-10-28 |
Virochem Pharma Inc |
Thiophene derivatives and their use for the treatment or prevention of flavivirus infections
|
CN100478349C
(zh)
*
|
2005-06-20 |
2009-04-15 |
河南省凯特化学实业总公司 |
氟化核苷类化合物、其制备方法及其应用
|
TWI387603B
(zh)
|
2005-07-20 |
2013-03-01 |
Merck Sharp & Dohme |
Hcv ns3蛋白酶抑制劑
|
RU2008107972A
(ru)
|
2005-08-01 |
2009-09-10 |
Мерк энд Ко., Инк. (US) |
Макроциклические пептиды в качестве ингибиторов ns3-протеазы hcv
|
AU2006275413B2
(en)
*
|
2005-08-02 |
2012-07-19 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases
|
US7964624B1
(en)
|
2005-08-26 |
2011-06-21 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases
|
AR055395A1
(es)
|
2005-08-26 |
2007-08-22 |
Vertex Pharma |
Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c
|
US7700567B2
(en)
|
2005-09-29 |
2010-04-20 |
Supergen, Inc. |
Oligonucleotide analogues incorporating 5-aza-cytosine therein
|
RU2422454C2
(ru)
|
2005-12-09 |
2011-06-27 |
Ф. Хоффманн-Ля Рош Аг |
Антивирусные нуклеозиды
|
US7781576B2
(en)
|
2005-12-23 |
2010-08-24 |
Idenix Pharmaceuticals, Inc. |
Process for preparing a synthetic intermediate for preparation of branched nucleosides
|
TW200800265A
(en)
*
|
2006-02-09 |
2008-01-01 |
Schering Corp |
Combinations comprising HCV protease inhibitor(s) and HCV polymerase inhibitor(s), and methods of treatment related thereto
|
WO2007098270A2
(fr)
|
2006-02-27 |
2007-08-30 |
Vertex Pharmaceuticals Incorporated |
Co-cristaux et compositions pharmaceutiques les comprenant
|
BRPI0709567A2
(pt)
|
2006-03-16 |
2011-07-12 |
Vertex Pharma |
inibidores deuterados de protease de hepatite c
|
WO2007113159A1
(fr)
|
2006-04-04 |
2007-10-11 |
F. Hoffmann-La Roche Ag |
Nucléosides 3',5'-di-o-acylés destinés au traitement du vhc
|
AU2007347115A1
(en)
|
2006-04-04 |
2008-10-23 |
The Regents Of The University Of California |
PI3 kinase antagonists
|
JP5167244B2
(ja)
|
2006-04-11 |
2013-03-21 |
ノバルティス アーゲー |
Hcv/hiv阻害剤およびそれらの使用
|
GB0609492D0
(en)
|
2006-05-15 |
2006-06-21 |
Angeletti P Ist Richerche Bio |
Therapeutic agents
|
GB0612423D0
(en)
|
2006-06-23 |
2006-08-02 |
Angeletti P Ist Richerche Bio |
Therapeutic agents
|
US7842672B2
(en)
|
2006-07-07 |
2010-11-30 |
Gilead Sciences, Inc. |
Phosphonate inhibitors of HCV
|
WO2008073165A2
(fr)
*
|
2006-08-25 |
2008-06-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Procédés et compositions permettant d'identifier des agents anti-hcv
|
ES2358853T3
(es)
|
2006-10-10 |
2011-05-16 |
Medivir Ab |
Inhibidor nucleosídico de vhc.
|
JP5252459B2
(ja)
|
2006-10-10 |
2013-07-31 |
ギリアド ファーマセット エルエルシー |
リボフラノシルピリミジンヌクレオシドの調製
|
AU2007309546A1
(en)
|
2006-10-24 |
2008-05-02 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
HCV NS3 protease inhibitors
|
US8309540B2
(en)
|
2006-10-24 |
2012-11-13 |
Merck Sharp & Dohme Corp. |
HCV NS3 protease inhibitors
|
US8138164B2
(en)
*
|
2006-10-24 |
2012-03-20 |
Merck Sharp & Dohme Corp. |
HCV NS3 protease inhibitors
|
WO2008057209A1
(fr)
|
2006-10-27 |
2008-05-15 |
Merck & Co., Inc. |
Inhibiteurs de protéase ns3 du vhc
|
WO2008057208A2
(fr)
|
2006-10-27 |
2008-05-15 |
Merck & Co., Inc. |
Inhibiteurs de protéase ns3 du vhc
|
KR101165936B1
(ko)
|
2006-11-09 |
2012-07-19 |
에프. 호프만-라 로슈 아게 |
티아졸 및 옥사졸-치환된 아릴아마이드
|
MX2009005185A
(es)
|
2006-11-15 |
2009-07-07 |
Virochem Pharma Inc |
Analogos de tiofeno para el tratamiento o prevencion de infecciones de flavivirus.
|
GB0623493D0
(en)
|
2006-11-24 |
2007-01-03 |
Univ Cardiff |
Chemical compounds
|
GB0625345D0
(en)
|
2006-12-20 |
2007-01-31 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
AU2007335962B2
(en)
*
|
2006-12-20 |
2012-09-06 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa |
Antiviral indoles
|
GB0625349D0
(en)
|
2006-12-20 |
2007-01-31 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
US7951789B2
(en)
*
|
2006-12-28 |
2011-05-31 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of viral infections
|
AU2007342367B2
(en)
|
2007-01-05 |
2012-12-06 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Nucleoside aryl phosphoramidates for the treatment of RNA-dependent RNA viral infection
|
TW200838550A
(en)
*
|
2007-02-09 |
2008-10-01 |
Novartis Ag |
Organic compounds
|
AP2009004960A0
(en)
|
2007-02-27 |
2009-08-31 |
Vertex Pharma |
Co-crystals and pharmaceutical compositions comprising the same
|
NZ579295A
(en)
|
2007-02-27 |
2012-03-30 |
Vertex Pharma |
Inhibitors of serine proteases
|
WO2008106167A1
(fr)
*
|
2007-02-28 |
2008-09-04 |
Conatus Pharmaceuticals, Inc. |
Polythérapie incluant des inhibiteurs de métalloprotéinases matricielles et des inhibiteurs de caspases pour le traitement de maladies hépatiques
|
AU2008219622A1
(en)
*
|
2007-02-28 |
2008-09-04 |
Conatus Pharmaceuticals, Inc. |
Methods for the treatment of liver diseases using specified matrix metalloproteinase (MMP) inhibitors
|
WO2008118013A2
(fr)
|
2007-03-23 |
2008-10-02 |
To-Bbb Holding B.V. |
Administration intracellulaire ciblée d'agents antiviraux
|
US7964580B2
(en)
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
EP2155758B1
(fr)
*
|
2007-05-10 |
2012-08-22 |
Biocryst Pharmaceuticals, Inc. |
Composés de tétrahydrofuro[3,4-d]-dioxolane pour utilisation dans le traitement d'infections virales et de cancer
|
GB0709791D0
(en)
*
|
2007-05-22 |
2007-06-27 |
Angeletti P Ist Richerche Bio |
Antiviral agents
|
WO2009005615A1
(fr)
*
|
2007-06-27 |
2009-01-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
Procédés et compositions pour identifier des agents qui inhibent un phénotype cellulaire néoplasique provoqué par ns4b de cellules infectées par le hcv
|
CN100532388C
(zh)
*
|
2007-07-16 |
2009-08-26 |
郑州大学 |
2’-氟-4’-取代-核苷类似物、其制备方法及应用
|
CA2693537C
(fr)
*
|
2007-07-17 |
2013-06-25 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa |
Derives macrocycliques d'indole pour le traitement des infections d'hepatite c
|
CA2699891C
(fr)
|
2007-07-19 |
2013-10-22 |
Nigel Liverton |
Composes macrocycliques servant d'agents antiviraux
|
US8492546B2
(en)
|
2007-08-30 |
2013-07-23 |
Vertex Pharmaceuticals Incorporated |
Co-crystals and pharmaceutical compositions comprising the same
|
GB0718575D0
(en)
|
2007-09-24 |
2007-10-31 |
Angeletti P Ist Richerche Bio |
Nucleoside derivatives as inhibitors of viral polymerases
|
WO2009046448A1
(fr)
*
|
2007-10-04 |
2009-04-09 |
Intellikine, Inc. |
Entités chimiques et leurs utilisations thérapeutiques
|
US20090318380A1
(en)
|
2007-11-20 |
2009-12-24 |
Pharmasset, Inc. |
2',4'-substituted nucleosides as antiviral agents
|
JP5498392B2
(ja)
|
2007-11-30 |
2014-05-21 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
1,5−ジヒドロ−ピラゾロ[3,4−d]ピリミジン−4−オン誘導体及びcns障害の治療のためのpde9aモジュレーターとしてのそれらの使用
|
BR122018070508B8
(pt)
|
2007-12-17 |
2021-07-27 |
Hoffmann La Roche |
derivados de arilamida triazol-substituída e seu uso
|
CA2708791C
(fr)
|
2007-12-17 |
2016-06-21 |
F. Hoffmann-La Roche Ag |
Arylamides a imidazole substitue et leurs utilisations comme antagonistes du recepteur p2x
|
CN103214464B
(zh)
|
2007-12-17 |
2015-02-18 |
霍夫曼-拉罗奇有限公司 |
四唑取代的芳基酰胺衍生物和它们作为p2x3和/或p2x2/3嘌呤能受体拮抗物的用途
|
EP2234976B1
(fr)
|
2007-12-17 |
2013-04-10 |
F. Hoffmann-La Roche AG |
Nouvelles arylamides substituées pyrazole
|
EP2240452B1
(fr)
|
2008-01-04 |
2019-05-29 |
Intellikine, LLC |
Dérivés de 1h-pyrazolo[3,4-d]pyrimidin-4-amine en tant que modulateurs de kinase pi3, leurs compositions et utilisations
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
US8993580B2
(en)
|
2008-03-14 |
2015-03-31 |
Intellikine Llc |
Benzothiazole kinase inhibitors and methods of use
|
JP5547099B2
(ja)
|
2008-03-14 |
2014-07-09 |
インテリカイン, エルエルシー |
キナーゼ阻害剤および使用方法
|
US8227431B2
(en)
|
2008-03-17 |
2012-07-24 |
Hetero Drugs Limited |
Nucleoside derivatives
|
TW200946541A
(en)
|
2008-03-27 |
2009-11-16 |
Idenix Pharmaceuticals Inc |
Solid forms of an anti-HIV phosphoindole compound
|
UA105362C2
(en)
|
2008-04-02 |
2014-05-12 |
Бьорингер Ингельхайм Интернациональ Гмбх |
1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
|
EP2268288A4
(fr)
*
|
2008-04-15 |
2012-05-30 |
Rfs Pharma Llc |
Dérivés nucléosidiques destinés au traitement d infections par un virus de la famille des caliciviridae, y compris d infections par le norovirus
|
PT2268642E
(pt)
|
2008-04-23 |
2015-06-02 |
Gilead Sciences Inc |
Análogos de carba-nulceósidos 1¿-substituídos para tratamento antiviral
|
AU2013216595B2
(en)
*
|
2008-04-23 |
2016-07-28 |
Gilead Sciences, Inc. |
1' -substituted carba-nucleoside analogs for antiviral treatment
|
US8461107B2
(en)
|
2008-04-28 |
2013-06-11 |
Merck Sharp & Dohme Corp. |
HCV NS3 protease inhibitors
|
CA2724523A1
(fr)
|
2008-06-06 |
2010-01-07 |
Scynexis, Inc. |
Nouveaux peptides macrocycliques
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
WO2009150156A1
(fr)
*
|
2008-06-13 |
2009-12-17 |
Riboxx Gmbh |
Procédé permettant la synthèse enzymatique de l'arn modifié chimiquement
|
KR20110065440A
(ko)
*
|
2008-07-02 |
2011-06-15 |
아이데닉스 파마슈티칼스, 인코포레이티드 |
바이러스 감염의 치료를 위한 화합물 및 제약 조성물
|
WO2010002877A2
(fr)
*
|
2008-07-03 |
2010-01-07 |
Biota Scientific Management |
Nucléosides bicycliques et nucléotides convenant comme agents thérapeutiques
|
CN102089318B
(zh)
|
2008-07-08 |
2014-05-21 |
吉里德科学公司 |
Hiv抑制剂化合物的盐
|
US20110224223A1
(en)
*
|
2008-07-08 |
2011-09-15 |
The Regents Of The University Of California, A California Corporation |
MTOR Modulators and Uses Thereof
|
CA2730106A1
(fr)
|
2008-07-08 |
2010-01-14 |
Intellikine, Inc. |
Inhibiteurs de kinases et procedes d'utilisation
|
DK2540350T3
(da)
|
2008-07-22 |
2014-08-04 |
Merck Sharp & Dohme |
Kombinationer af en makrocyklisk quinoxalinforbindelse, hvilken er enhcv-ns3-protease-inhibitor med andre hcv-midler
|
JP4621926B2
(ja)
*
|
2008-07-24 |
2011-02-02 |
国立大学法人九州大学 |
酵素基質修飾ヌクレオシド三リン酸、核酸プローブ、マルチラベル化核酸プローブ、マルチラベル化核酸プローブの製造方法および標的核酸の検出方法
|
JP5146785B2
(ja)
*
|
2008-07-24 |
2013-02-20 |
国立大学法人九州大学 |
酵素基質修飾ヌクレオシド三リン酸誘導体
|
WO2010015637A1
(fr)
*
|
2008-08-06 |
2010-02-11 |
Novartis Ag |
Nouveaux nucléosides modifiés antiviraux
|
UA103195C2
(uk)
|
2008-08-11 |
2013-09-25 |
Глаксосмитклайн Ллк |
Похідні пурину для застосування у лікуванні алергій, запальних та інфекційних захворювань
|
EP3246030A1
(fr)
|
2008-08-11 |
2017-11-22 |
GlaxoSmithKline LLC |
Nouveaux dérivés d'adénine
|
WO2010018131A1
(fr)
|
2008-08-11 |
2010-02-18 |
Smithkline Beecham Corporation |
Dérivés purines destinés à être utilisés dans le traitement de maladies allergiques, inflammatoires et infectieuses
|
PE20110383A1
(es)
|
2008-09-08 |
2011-07-15 |
Boehringer Ingelheim Int |
Pirazolopirimidinonas como inhibidores de la fosfodiesterasa 9a (pde9a)
|
JP5731978B2
(ja)
|
2008-09-26 |
2015-06-10 |
インテリカイン, エルエルシー |
複素環キナーゼ阻害剤
|
EP3025727A1
(fr)
|
2008-10-02 |
2016-06-01 |
The J. David Gladstone Institutes |
Procédés de traitement des maladies du foie
|
AU2009305669A1
(en)
|
2008-10-16 |
2010-04-22 |
The Regents Of The University Of California |
Fused ring heteroaryl kinase inhibitors
|
US8476431B2
(en)
*
|
2008-11-03 |
2013-07-02 |
Itellikine LLC |
Benzoxazole kinase inhibitors and methods of use
|
ES2616051T3
(es)
|
2008-12-02 |
2017-06-09 |
Wave Life Sciences Japan, Inc. |
Método para la síntesis de ácidos nucleicos modificados en el átomo de fósforo
|
SG172359A1
(en)
|
2008-12-23 |
2011-07-28 |
Pharmasset Inc |
Nucleoside phosphoramidates
|
CL2009002208A1
(es)
|
2008-12-23 |
2010-10-29 |
Gilead Pharmasset Llc |
Un compuesto (2s)-2-((((2r,3r,4r,5r)-5-(2-amino-6-etoxi-9h-purin-9-il)-4-fluoro-3-hidroxi-4-metiltetrahidrofuran-2-il)metoxi)(hidroxi)fosforilamino)propanoico, inhibidores de la replicacion de arn viral; composicion farmaceutica; y su uso en el tratamiento de infeccion por hepatitis c, virus del nilo occidental, entre otras.
|
KR20110104074A
(ko)
|
2008-12-23 |
2011-09-21 |
파마셋 인코포레이티드 |
퓨린 뉴클레오시드의 합성
|
WO2010082050A1
(fr)
|
2009-01-16 |
2010-07-22 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Composés benzoxazocines substitués 7-aminoalkyle macrocycycliques destinés au traitement des infections par hépatite c
|
GB0900914D0
(en)
|
2009-01-20 |
2009-03-04 |
Angeletti P Ist Richerche Bio |
Antiviral agents
|
PE20120020A1
(es)
*
|
2009-01-21 |
2012-02-02 |
Hoffmann La Roche |
Composicion farmaceutica que comprende un profarmaco inhibidor de la polimerasa de vhc
|
ES2453078T3
(es)
|
2009-02-10 |
2014-04-03 |
Gilead Sciences, Inc. |
Análogos de carba-nucleósido para tratamiento antiviral
|
JP2012517478A
(ja)
|
2009-02-12 |
2012-08-02 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
ペグ化インターフェロン、リバビリンおよびテラプレビルを含む、hcv組合せ治療剤
|
JP5690286B2
(ja)
|
2009-03-04 |
2015-03-25 |
イデニク プハルマセウティカルス,インコーポレイテッド |
ホスホチオフェン及びホスホチアゾールhcvポリメラーゼ阻害剤
|
CN102448458B
(zh)
|
2009-03-18 |
2015-07-22 |
小利兰·斯坦福大学理事会 |
治疗黄病毒科病毒感染的方法和组合物
|
EA201190178A1
(ru)
|
2009-03-20 |
2012-06-29 |
Алиос Биофарма, Инк. |
Замещённые нуклеозидные и нуклеотидные аналоги
|
KR20120003868A
(ko)
|
2009-03-31 |
2012-01-11 |
베링거 인겔하임 인터내셔날 게엠베하 |
1―헤테로사이클릴―1,5―디하이드로―피라졸로[3,4―d]피리미딘―4―온 유도체 및 pde9a 조절인자로서의 이의 용도
|
US20110182850A1
(en)
|
2009-04-10 |
2011-07-28 |
Trixi Brandl |
Organic compounds and their uses
|
US8512690B2
(en)
|
2009-04-10 |
2013-08-20 |
Novartis Ag |
Derivatised proline containing peptide compounds as protease inhibitors
|
NZ700583A
(en)
*
|
2009-04-22 |
2016-04-29 |
Acad Of Science Czech Republic |
Novel 7-deazapurine nucleosides for therapeutic uses
|
JP5789252B2
(ja)
|
2009-05-07 |
2015-10-07 |
インテリカイン, エルエルシー |
複素環式化合物およびその使用
|
JO3027B1
(ar)
*
|
2009-05-14 |
2016-09-05 |
Janssen Products Lp |
نيوكليوسيدات يوراسيل سبيرواوكسيتان
|
TWI583692B
(zh)
|
2009-05-20 |
2017-05-21 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
US20100297079A1
(en)
*
|
2009-05-20 |
2010-11-25 |
Chimerix, Inc. |
Compounds, compositions and methods for treating viral infection
|
US8618076B2
(en)
|
2009-05-20 |
2013-12-31 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
US9676797B2
(en)
|
2015-09-02 |
2017-06-13 |
Abbvie Inc. |
Anti-viral compounds
|
CN102438989B
(zh)
|
2009-06-22 |
2015-05-27 |
霍夫曼-拉罗奇有限公司 |
噁唑酮和吡咯烷酮取代的芳基酰胺
|
SG177308A1
(en)
|
2009-06-22 |
2012-02-28 |
Hoffmann La Roche |
Novel biphenyl and phenyl-pyridine amides
|
SG177301A1
(en)
|
2009-06-22 |
2012-02-28 |
Hoffmann La Roche |
Novel indole, indazole and benzimidazole arylamides as p2x3 and/or p2x2/3 antagonists
|
JP5998326B2
(ja)
|
2009-07-06 |
2016-09-28 |
ウェイブ ライフ サイエンス リミテッドWave Life Sciences Ltd. |
新規核酸プロドラッグおよびその使用方法
|
EP2459582B1
(fr)
|
2009-07-30 |
2015-05-27 |
Merck Sharp & Dohme Corp. |
Inhibiteurs de protéase ns3 du virus de l'hépatite c
|
WO2011017389A1
(fr)
|
2009-08-05 |
2011-02-10 |
Idenix Pharmaceuticals, Inc. |
Inhibiteurs macrocycliques de la sérine protéase macrocyclique utiles contre les infections virales, en particulier le virus de lhépatite c
|
AR077859A1
(es)
|
2009-08-12 |
2011-09-28 |
Boehringer Ingelheim Int |
Compuestos para el tratamiento de trastornos del snc
|
US8796394B2
(en)
*
|
2009-08-27 |
2014-08-05 |
Northwestern University |
Antifouling hydrogels, coatings, and methods of synthesis and use thereof
|
US7973013B2
(en)
|
2009-09-21 |
2011-07-05 |
Gilead Sciences, Inc. |
2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
|
US8455451B2
(en)
|
2009-09-21 |
2013-06-04 |
Gilead Sciences, Inc. |
2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
|
US10023600B2
(en)
|
2009-09-21 |
2018-07-17 |
Gilead Sciences, Inc. |
Processes and intermediates for the preparation of 1′-substituted carba-nucleoside analogs
|
SG179194A1
(en)
*
|
2009-09-21 |
2012-05-30 |
Gilead Sciences Inc |
2' -fluoro substituted carba-nucleoside analogs for antiviral treatment
|
US8980899B2
(en)
|
2009-10-16 |
2015-03-17 |
The Regents Of The University Of California |
Methods of inhibiting Ire1
|
EP2493889B1
(fr)
|
2009-10-30 |
2017-09-06 |
Janssen Pharmaceutica, N.V. |
Dérivés d'imidazo[1,2-b]pyridazine et leur utilisation en tant qu'inhibiteurs pde10
|
CA2780044A1
(fr)
|
2009-11-14 |
2011-05-19 |
F. Hoffmann-La Roche Ag |
Marqueurs biologiques destines a predire une reaction rapide au traitement du virus de l'hepatite c (hcv)
|
MX2012005601A
(es)
*
|
2009-11-16 |
2012-08-01 |
Univ Georgia |
Nucleosidos carboxiclicos de 2'-fluoro-6'-metileno y metodos para tratar infecciones virales.
|
WO2011063076A1
(fr)
|
2009-11-19 |
2011-05-26 |
Itherx Pharmaceuticals, Inc. |
Méthodes de traitement du virus de l'hépatite c avec des composés d'oxo-acétamide
|
WO2011068715A1
(fr)
|
2009-11-25 |
2011-06-09 |
Vertex Pharmaceuticals Incorporated |
Dérivés d'acide 5-alcynyl-thiophène-2-carboxylique et leur utilisation pour traiter ou prévenir des infections à flavivirus
|
SG181104A1
(en)
|
2009-12-02 |
2012-07-30 |
Hoffmann La Roche |
Biomarkers for predicting sustained response to hcv treatment
|
JP2013514982A
(ja)
|
2009-12-18 |
2013-05-02 |
イデニク プハルマセウティカルス,インコーポレイテッド |
5,5−縮合アリーレン又はヘテロアリーレンc型肝炎ウイルス阻害剤
|
US20130072523A1
(en)
|
2009-12-24 |
2013-03-21 |
Vertex Pharmaceuticals Incorporated |
Analogues for the treatment or prevention of flavivirus infections
|
JP5704481B2
(ja)
*
|
2010-01-22 |
2015-04-22 |
国立大学法人九州大学 |
核酸検出用キット
|
PT2528930E
(pt)
*
|
2010-01-28 |
2013-11-26 |
Hoffmann La Roche |
Nucleósidos de 4'-azido como compostos anti-vhc
|
CN102844030A
(zh)
|
2010-01-29 |
2012-12-26 |
沃泰克斯药物股份有限公司 |
用于治疗丙型肝炎病毒感染的疗法
|
US8575340B2
(en)
|
2010-02-10 |
2013-11-05 |
Glaxosmithkline Llc |
Purine derivatives and their pharmaceutical uses
|
US8703754B2
(en)
|
2010-02-10 |
2014-04-22 |
Glaxosmithkline Llc |
6-amino-2-{[(1S)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)-7,9-dihydro-8H-purin-8-one maleate
|
AR080754A1
(es)
|
2010-03-09 |
2012-05-09 |
Janssen Pharmaceutica Nv |
Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10
|
CN103038237A
(zh)
|
2010-03-24 |
2013-04-10 |
沃泰克斯药物股份有限公司 |
用于黄病毒感染治疗或预防的类似物
|
WO2011119858A1
(fr)
|
2010-03-24 |
2011-09-29 |
Vertex Pharmaceuticals Incorporated |
Analogues destinés au traitement ou à la prévention d'infections à flavivirus
|
TW201141857A
(en)
|
2010-03-24 |
2011-12-01 |
Vertex Pharma |
Analogues for the treatment or prevention of flavivirus infections
|
WO2011119853A1
(fr)
|
2010-03-24 |
2011-09-29 |
Vertex Pharmaceuticals Incorporated |
Analogues pour traiter ou prévenir les infections à flavivirus
|
KR101715981B1
(ko)
|
2010-03-31 |
2017-03-13 |
길리애드 파마셋 엘엘씨 |
뉴클레오사이드 포스포르아미데이트
|
PL3290428T3
(pl)
|
2010-03-31 |
2022-02-07 |
Gilead Pharmasset Llc |
Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu
|
SI2609923T1
(sl)
|
2010-03-31 |
2017-10-30 |
Gilead Pharmasset Llc |
Postopek za kristalizacijo (s)-izopropil 2-(((s)-(perfluorofenoksi) (fenoksi)fosforil)amino)propanoata
|
US8680071B2
(en)
|
2010-04-01 |
2014-03-25 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of viral infections
|
AU2011255218B2
(en)
|
2010-05-21 |
2015-03-12 |
Infinity Pharmaceuticals, Inc. |
Chemical compounds, compositions and methods for kinase modulation
|
TW201201815A
(en)
*
|
2010-05-28 |
2012-01-16 |
Gilead Sciences Inc |
1'-substituted-carba-nucleoside prodrugs for antiviral treatment
|
WO2011156545A1
(fr)
|
2010-06-09 |
2011-12-15 |
Vertex Pharmaceuticals Incorporated |
Modèle dynamique viral pour une polythérapie contre le vhc
|
US20130157258A1
(en)
|
2010-06-15 |
2013-06-20 |
Vertex Pharmaceuticals Incorporated |
Hcv ns5b protease mutants
|
WO2012006070A1
(fr)
|
2010-06-28 |
2012-01-12 |
Vertex Pharmaceuticals Incorporated |
Composés et méthodes de traitement ou de prévention d'infections à flavivirus
|
JP2013531011A
(ja)
|
2010-06-28 |
2013-08-01 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
フラビウイルス感染の処置または予防のための化合物および方法
|
MX2012014918A
(es)
|
2010-06-28 |
2013-04-08 |
Vertex Pharma |
Compuestos y metodos para tratamiento o prevencion de infecciones por flavivirus.
|
US20120014912A1
(en)
|
2010-07-14 |
2012-01-19 |
Vertex Pharmaceuticals Incorporated |
Palatable pharmaceutical composition
|
KR102108864B1
(ko)
|
2010-07-19 |
2020-05-12 |
길리애드 사이언시즈, 인코포레이티드 |
부분입체 이성질성으로 순수한 포스포라미데이트 전구약물의 제조 방법
|
SG186830A1
(en)
|
2010-07-22 |
2013-02-28 |
Gilead Sciences Inc |
Methods and compounds for treating paramyxoviridae virus infections
|
BR112013003097B1
(pt)
|
2010-08-12 |
2021-03-16 |
Boehringer Ingelheim International Gmbh |
6-cicloalquil-pirazolopirimidinonas e composição farmacêutica
|
CN103153978A
(zh)
|
2010-08-17 |
2013-06-12 |
沃泰克斯药物股份有限公司 |
用于治疗或预防黄病毒科病毒感染的化合物和方法
|
WO2012039791A1
(fr)
*
|
2010-09-20 |
2012-03-29 |
Gilead Sciences, Inc. |
Analogues carbanucléosidiques 2'-fluoro-substitués pour traitement antiviral
|
CA2812962C
(fr)
|
2010-09-22 |
2020-03-31 |
Alios Biopharma, Inc. |
Azido nucleosides et analogues nucleotidiques
|
US8871737B2
(en)
|
2010-09-22 |
2014-10-28 |
Alios Biopharma, Inc. |
Substituted nucleotide analogs
|
US10428019B2
(en)
|
2010-09-24 |
2019-10-01 |
Wave Life Sciences Ltd. |
Chiral auxiliaries
|
BR112013008510A2
(pt)
|
2010-10-08 |
2016-07-05 |
Novartis Ag |
vitamina e formulações de inibidores de sulfamida ns3
|
WO2012064973A2
(fr)
|
2010-11-10 |
2012-05-18 |
Infinity Pharmaceuticals, Inc. |
Composés hétérocycliques et utilisations de ceux-ci
|
AR084044A1
(es)
|
2010-11-30 |
2013-04-17 |
Pharmasset Inc |
Compuestos 2’-espiro-nucleosidos
|
WO2012080050A1
(fr)
|
2010-12-14 |
2012-06-21 |
F. Hoffmann-La Roche Ag |
Formes solides d'un composé de phénoxybenzènesulfonyle
|
CA2819041A1
(fr)
|
2010-12-22 |
2012-06-28 |
Alios Biopharma, Inc. |
Analogues de nucleotides cycliques
|
NZ612909A
(en)
|
2011-01-10 |
2015-09-25 |
Infinity Pharmaceuticals Inc |
Processes for preparing isoquinolinones and solid forms of isoquinolinones
|
US9353100B2
(en)
|
2011-02-10 |
2016-05-31 |
Idenix Pharmaceuticals Llc |
Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections
|
WO2012109646A1
(fr)
|
2011-02-11 |
2012-08-16 |
Vertex Pharmaceuticals Incorporated |
Traitement du vhc chez des patients infectés par le vih
|
US20130040971A1
(en)
|
2011-02-14 |
2013-02-14 |
Boehringer Ingelheim International Gmbh |
6-cycloalkyl-pyrazolopyrimidinones for the treatment of cns disorders
|
US8809345B2
(en)
|
2011-02-15 |
2014-08-19 |
Boehringer Ingelheim International Gmbh |
6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders
|
CN106619647A
(zh)
|
2011-02-23 |
2017-05-10 |
因特利凯有限责任公司 |
激酶抑制剂的组合及其用途
|
CN103842369A
(zh)
|
2011-03-31 |
2014-06-04 |
埃迪尼克斯医药公司 |
用于治疗病毒感染的化合物和药物组合物
|
US20120252721A1
(en)
|
2011-03-31 |
2012-10-04 |
Idenix Pharmaceuticals, Inc. |
Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
|
US9156872B2
(en)
|
2011-04-13 |
2015-10-13 |
Merck Sharp & Dohme Corp. |
2′-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
US9061041B2
(en)
|
2011-04-13 |
2015-06-23 |
Merck Sharp & Dohme Corp. |
2′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
CN103476783A
(zh)
|
2011-04-13 |
2013-12-25 |
吉里德科学公司 |
用于抗病毒治疗的1’-取代的嘧啶n-核苷类似物
|
CA2832449A1
(fr)
|
2011-04-13 |
2012-10-18 |
Vinay GIRIJAVALLABHAN |
Derives nucleosides a substitution 2'-cyano et leurs procedes d'utilisation pour traitement de maladies virales
|
EA027418B1
(ru)
|
2011-06-27 |
2017-07-31 |
Янссен Фармацевтика Нв |
ПРОИЗВОДНЫЕ 1-АРИЛ-4-МЕТИЛ[1,2,4]ТРИАЗОЛО[4,3-a]ХИНОКСАЛИНА, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ИХ ОСНОВЕ, СПОСОБЫ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ ИХ, ПРОМЕЖУТОЧНЫЕ СОЕДИНЕНИЯ
|
EP2731433A4
(fr)
|
2011-07-13 |
2014-12-31 |
Merck Sharp & Dohme |
Analogues de nucléosides 5'-substitués et leurs procédés d'utilisation pour le traitement de maladies virales
|
EP2731434A4
(fr)
|
2011-07-13 |
2014-12-31 |
Merck Sharp & Dohme |
Dérivés de nucléosides 5'-substitués et leurs procédés d'utilisation pour le traitement de maladies virales
|
EP3248982A1
(fr)
|
2011-07-19 |
2017-11-29 |
Wave Life Sciences Ltd. |
Reactifs de type thiosulfonate pour la synthèse d'acides nucléiques fonctionnalisés
|
CN103930422A
(zh)
|
2011-07-19 |
2014-07-16 |
无限药品股份有限公司 |
杂环化合物及其用途
|
MX2014000648A
(es)
|
2011-07-19 |
2014-09-25 |
Infinity Pharmaceuticals Inc |
Compuestos heterociclicos y sus usos.
|
AR087344A1
(es)
|
2011-07-26 |
2014-03-19 |
Vertex Pharma |
Formas polimorficas del acido 5-(3,3-dimetil-but-1-inil)-3-[(trans-4-hidroxi-ciclohexil)-(trans-4-metil-ciclohexancarbonil)-amino]-tiofen-2-carboxilico y su uso en el tratamiento de la hepatitis c
|
WO2013016499A1
(fr)
|
2011-07-26 |
2013-01-31 |
Vertex Pharmaceuticals Incorporated |
Procédés de préparation de composés du thiophène
|
AR091790A1
(es)
|
2011-08-29 |
2015-03-04 |
Infinity Pharmaceuticals Inc |
Derivados de isoquinolin-1-ona y sus usos
|
SG2014013395A
(en)
|
2011-08-30 |
2014-05-29 |
Astex Pharmaceuticals Inc |
Decitabine derivative formulations
|
EP2825546B1
(fr)
|
2011-09-01 |
2017-07-12 |
Case Western Reserve University |
Nucléosides non endogènes en tant qu'agents théranostiques
|
WO2013077921A2
(fr)
|
2011-09-02 |
2013-05-30 |
The Regents Of The University Of California |
Pyrazolo[3,4-d]pyrimidines substituées et utilisations de celles-ci
|
US9403863B2
(en)
|
2011-09-12 |
2016-08-02 |
Idenix Pharmaceuticals Llc |
Substituted carbonyloxymethylphosphoramidate compounds and pharmaceutical compositions for the treatment of viral infections
|
CA2847892A1
(fr)
|
2011-09-12 |
2013-03-21 |
Idenix Pharmaceuticals, Inc. |
Composes et compositions pharmaceutiques pour le traitement d'infections virales
|
MD4589C1
(ro)
|
2011-09-16 |
2019-03-31 |
Gilead Pharmasset Llc |
Compoziţie farmaceutică cu conţinut de sofosbuvir şi utilizarea acesteia în tratamentul hepatitei virale C
|
US8507460B2
(en)
|
2011-10-14 |
2013-08-13 |
Idenix Pharmaceuticals, Inc. |
Substituted 3′,5′-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infections
|
US8492386B2
(en)
|
2011-10-21 |
2013-07-23 |
Abbvie Inc. |
Methods for treating HCV
|
US8466159B2
(en)
|
2011-10-21 |
2013-06-18 |
Abbvie Inc. |
Methods for treating HCV
|
EP2583680A3
(fr)
|
2011-10-21 |
2013-06-12 |
Abbvie Inc. |
Traitement seul (PSI-7977) ou combinatoire dans l'utilisation pour le traitement du VHC
|
SE1450130A1
(sv)
|
2011-10-21 |
2014-05-07 |
Abbvie Inc |
Förfaranden för att behandla hcv innefattande minst två direktverkande antivirala agenser, ribavirin men inte interferon
|
US20140286903A1
(en)
*
|
2011-11-10 |
2014-09-25 |
Inhibitex, Inc. |
Substituted Purine Nucleosides, Phosphoramidate and Phosphordiamidate Derivatives for Treatment if Viral Infections
|
WO2013074386A2
(fr)
|
2011-11-15 |
2013-05-23 |
Merck Sharp & Dohme Corp. |
Inhibiteurs de la protéase ns3 du vhc
|
US8889159B2
(en)
|
2011-11-29 |
2014-11-18 |
Gilead Pharmasset Llc |
Compositions and methods for treating hepatitis C virus
|
US9089574B2
(en)
|
2011-11-30 |
2015-07-28 |
Emory University |
Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections
|
WO2013084165A1
(fr)
*
|
2011-12-05 |
2013-06-13 |
Medivir Ab |
Inhibiteurs de vhc polymérase
|
WO2013086133A1
(fr)
|
2011-12-06 |
2013-06-13 |
The Board Of Trustees Of The Leland Stanford Junior University |
Méthodes et compositions pour le traitement de maladies virales
|
EP2794630A4
(fr)
|
2011-12-22 |
2015-04-01 |
Alios Biopharma Inc |
Analogues de nucléotide phosphorothioate substitués
|
DK2794627T3
(en)
|
2011-12-22 |
2019-01-14 |
Alios Biopharma Inc |
SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGUES THEREOF
|
US20140356325A1
(en)
|
2012-01-12 |
2014-12-04 |
Ligand Pharmaceuticals Incorporated |
Novel 2'-c-methyl nucleoside derivative compounds
|
WO2013116339A1
(fr)
|
2012-01-31 |
2013-08-08 |
Vertex Pharmaceuticals Incorporated |
Formulations très puissantes de vx-950
|
US20130217644A1
(en)
|
2012-02-13 |
2013-08-22 |
Idenix Pharmaceuticals, Inc. |
Pharmaceutical Compositions of 2'-C-Methyl-Guanosine, 5'-[2[(3-Hydroxy-2,2-Dimethyl-1-Oxopropyl)Thio]Ethyl N-(Phenylmethyl)Phosphoramidate]
|
BR112014019897A8
(pt)
|
2012-02-14 |
2017-07-11 |
Univ Georgia |
Espiro[2.4]heptanos para tratamento de infecções por flaviviridae
|
EA201791916A1
(ru)
*
|
2012-03-13 |
2018-07-31 |
Джилид Сайэнс, Инк. |
2'-замещенные карбануклеозидные аналоги для противовирусного лечения
|
US8916538B2
(en)
|
2012-03-21 |
2014-12-23 |
Vertex Pharmaceuticals Incorporated |
Solid forms of a thiophosphoramidate nucleotide prodrug
|
US9441007B2
(en)
|
2012-03-21 |
2016-09-13 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
CN110917205A
(zh)
|
2012-03-21 |
2020-03-27 |
詹森生物制药有限公司 |
取代的核苷、核苷酸及其类似物
|
USRE48171E1
(en)
|
2012-03-21 |
2020-08-25 |
Janssen Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
NZ630805A
(en)
|
2012-03-22 |
2016-01-29 |
Alios Biopharma Inc |
Pharmaceutical combinations comprising a thionucleotide analog
|
US8940742B2
(en)
|
2012-04-10 |
2015-01-27 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
WO2013177188A1
(fr)
|
2012-05-22 |
2013-11-28 |
Idenix Pharmaceuticals, Inc. |
Promédicaments de 3',5'-phosphoramidate cyclique pour traiter une infection par le virus de l'hépatite c
|
MD20140134A2
(ro)
|
2012-05-22 |
2015-04-30 |
Idenix Pharmaceuticals, Inc. |
Compuşi ai D-aminoacizilor pentru tratamentul bolilor hepatice
|
WO2013177195A1
(fr)
|
2012-05-22 |
2013-11-28 |
Idenix Pharmaceuticals, Inc. |
Promédicaments de 3',5'-phosphate cyclique pour traiter une infection par le virus de l'hépatite c
|
CN104395330B
(zh)
|
2012-05-25 |
2018-03-13 |
爱尔兰詹森科学公司 |
尿嘧啶基螺氧杂环丁烷核苷
|
US9206412B2
(en)
*
|
2012-05-31 |
2015-12-08 |
Colorado State University Research Foundation |
Thioxothiazolidine inhibitors
|
US8828998B2
(en)
|
2012-06-25 |
2014-09-09 |
Infinity Pharmaceuticals, Inc. |
Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
|
CA2872216C
(fr)
|
2012-06-26 |
2021-07-20 |
Janssen Pharmaceutica Nv |
Combinaisons comprenant des inhibiteurs de la pde 2 tels que des composes 1-aryl-4-methyl-[1,2,4]triazolo [4,3-a]-quinoxaline et des inhibiteurs de la pde 10 pour utilisation dans le traitement de troublesneurologiques ou metaboliques
|
US9550784B2
(en)
|
2012-07-09 |
2017-01-24 |
Beerse Pharmaceutica NV |
Inhibitors of phosphodiesterase 10 enzyme
|
PL2872147T3
(pl)
|
2012-07-13 |
2023-09-25 |
Wave Life Sciences Ltd. |
Sposób wytwarzania chiralnych oligonukleotydów
|
KR101835401B1
(ko)
|
2012-07-13 |
2018-03-08 |
신 니뽄 바이오메디칼 라보라토리즈, 엘티디. |
키랄 핵산 어쥬번트
|
SG11201500239VA
(en)
|
2012-07-13 |
2015-03-30 |
Wave Life Sciences Japan |
Asymmetric auxiliary group
|
WO2014033617A1
(fr)
|
2012-08-31 |
2014-03-06 |
Novartis Ag |
Dérivés de 2'-éthynyle nucléoside de traitement d'infections virales
|
JP2015532287A
(ja)
|
2012-09-26 |
2015-11-09 |
ザ・リージエンツ・オブ・ザ・ユニバーシテイー・オブ・カリフオルニア |
Ire1の調節
|
US9192621B2
(en)
|
2012-09-27 |
2015-11-24 |
Idenix Pharmaceuticals Llc |
Esters and malonates of SATE prodrugs
|
CN104936970A
(zh)
|
2012-10-08 |
2015-09-23 |
埃迪尼克斯医药公司 |
用于hcv感染的2′-氯核苷类似物
|
US9242988B2
(en)
|
2012-10-17 |
2016-01-26 |
Merck Sharp & Dohme Corp. |
2′-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
AR092959A1
(es)
|
2012-10-17 |
2015-05-06 |
Merck Sharp & Dohme |
Derivados de nucleosidos 2-metil sustituidos y metodos de uso de los mismos para el tratamiento de enfermedades virales
|
EP2909210A4
(fr)
|
2012-10-17 |
2016-04-06 |
Merck Sharp & Dohme |
Dérivés nucléosides substitués 2'-disubstitués et leurs procédés d'utilisation pour le traitement de maladies virales
|
WO2014063019A1
(fr)
|
2012-10-19 |
2014-04-24 |
Idenix Pharmaceuticals, Inc. |
Composés dinucléotides contre une infection par le vhc
|
EP2909222B1
(fr)
|
2012-10-22 |
2021-05-26 |
Idenix Pharmaceuticals LLC |
Nucléosides 2', 4'-pontés pour l'infection par le vhc
|
US20140140952A1
(en)
|
2012-11-14 |
2014-05-22 |
Idenix Pharmaceuticals, Inc. |
D-Alanine Ester of Sp-Nucleoside Analog
|
EP2920195A1
(fr)
|
2012-11-14 |
2015-09-23 |
IDENIX Pharmaceuticals, Inc. |
Ester de d-alanine d'analogue de rp-nucléoside
|
EP2919792B1
(fr)
|
2012-11-19 |
2020-05-20 |
Merck Sharp & Dohme Corp. |
Dérivés de nucléoside à substitution alkynyle en position 2 pour le traitement de maladies virales
|
WO2014099941A1
(fr)
|
2012-12-19 |
2014-06-26 |
Idenix Pharmaceuticals, Inc. |
4'-fluoro-nucléosides pour le traitement du vhc
|
WO2014100505A1
(fr)
|
2012-12-21 |
2014-06-26 |
Alios Biopharma, Inc. |
Nucléosides, nucléotides substitués et leurs analogues
|
AU2013361193B2
(en)
*
|
2012-12-21 |
2018-05-24 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
MY172166A
(en)
|
2013-01-31 |
2019-11-15 |
Gilead Pharmasset Llc |
Combination formulation of two antiviral compounds
|
WO2014121418A1
(fr)
|
2013-02-07 |
2014-08-14 |
Merck Sharp & Dohme Corp. |
Composés hétérocycliques tétracycliques et leurs méthodes d'utilisation pour le traitement de l'hépatite c
|
WO2014121416A1
(fr)
|
2013-02-07 |
2014-08-14 |
Merck Sharp & Dohme Corp. |
Composés hétérocycliques tétracycliques et leurs procédés d'utilisation pour le traitement de l'hépatite c
|
WO2014121417A1
(fr)
|
2013-02-07 |
2014-08-14 |
Merck Sharp & Dohme Corp. |
Composés hétérocycliques tétracycliques et leurs procédés d'utilisation pour le traitement de l'hépatite c
|
US9821173B2
(en)
*
|
2013-02-08 |
2017-11-21 |
Case Western Reserve University |
Anti-cancer agents and methods of use
|
US20150065439A1
(en)
|
2013-02-28 |
2015-03-05 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions
|
EP2970358B1
(fr)
|
2013-03-04 |
2021-06-30 |
Idenix Pharmaceuticals LLC |
3'-désoxynucléosides utilisables en vue du traitement d'une infection par le vhc
|
US9339541B2
(en)
|
2013-03-04 |
2016-05-17 |
Merck Sharp & Dohme Corp. |
Thiophosphate nucleosides for the treatment of HCV
|
US20140271547A1
(en)
|
2013-03-13 |
2014-09-18 |
Idenix Pharmaceuticals, Inc. |
Amino acid phosphoramidate pronucleotides of 2'-cyano, azido and amino nucleosides for the treatment of hcv
|
US9481667B2
(en)
|
2013-03-15 |
2016-11-01 |
Infinity Pharmaceuticals, Inc. |
Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
|
RU2534613C2
(ru)
|
2013-03-22 |
2014-11-27 |
Александр Васильевич Иващенко |
Алкил 2-{ [(2r,3s,5r)-5-(4-амино-2-оксо-2н-пиримидин-1-ил)- -гидрокси-тетрагидро-фуран-2-илметокси]-фенокси-фосфориламино} -пропионаты, нуклеозидные ингибиторы рнк-полимеразы hcv ns5b, способы их получения и применения
|
US9187515B2
(en)
|
2013-04-01 |
2015-11-17 |
Idenix Pharmaceuticals Llc |
2′,4′-fluoro nucleosides for the treatment of HCV
|
WO2014169280A2
(fr)
|
2013-04-12 |
2014-10-16 |
Achillion Pharmaceuticals, Inc. |
Promédicaments de nucléoside deutérisé utilisés pour traiter l'hépatite c
|
WO2014197578A1
(fr)
|
2013-06-05 |
2014-12-11 |
Idenix Pharmaceuticals, Inc. |
1',4'-thio nucléosides pour le traitement du virus de l'hépatite c (vhc)
|
EA201592075A1
(ru)
|
2013-06-26 |
2016-05-31 |
Алиос Биофарма, Инк. |
Замещенные нуклеозиды, нуклеотиды и их аналоги
|
US9815864B2
(en)
|
2013-06-26 |
2017-11-14 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
US20150037282A1
(en)
|
2013-08-01 |
2015-02-05 |
Idenix Pharmaceuticals, Inc. |
D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease
|
PL3650014T3
(pl)
|
2013-08-27 |
2022-01-31 |
Gilead Pharmasset Llc |
Preparat złożony dwóch związków przeciwwirusowych
|
US20160229866A1
(en)
|
2013-09-20 |
2016-08-11 |
Idenix Pharmaceuticals Inc. |
Hepatitis c virus inhibitors
|
WO2015042447A1
(fr)
|
2013-09-20 |
2015-03-26 |
Isis Pharmaceuticals, Inc. |
Nucléosides thérapeutiques ciblées et leur utilisation
|
SG10201902074UA
(en)
|
2013-10-04 |
2019-04-29 |
Infinity Pharmaceuticals Inc |
Heterocyclic compounds and uses thereof
|
WO2015051241A1
(fr)
|
2013-10-04 |
2015-04-09 |
Infinity Pharmaceuticals, Inc. |
Composés hétérocycliques et leurs utilisations
|
CA2927010C
(fr)
*
|
2013-10-11 |
2022-06-07 |
Alios Biopharma, Inc. |
Nucleosides substitues, nucleotides substitues et analogues de ceux-ci
|
WO2015061683A1
(fr)
|
2013-10-25 |
2015-04-30 |
Idenix Pharmaceuticals, Inc. |
Pronucléotides thiophosphoramidates à acide aminé d et pronucléotides thiophosphoramidates à d-analine de composés de nucléoside utiles pour le traitement du vhc
|
US20160271162A1
(en)
|
2013-11-01 |
2016-09-22 |
Idenix Pharmacueticals, Llc |
D-alanine phosphoramide pronucleotides of 2'-methyl 2'-fluro guanosine nucleoside compounds for the treatment of hcv
|
CZ305466B6
(cs)
*
|
2013-11-04 |
2015-10-14 |
Ústav organické chemie a biochemie Akademie věd České republiky, v. v. i. |
Substituované 7-deazapurinové ribonukleosidy pro terapeutické použití
|
EP3074399A1
(fr)
|
2013-11-27 |
2016-10-05 |
Idenix Pharmaceuticals LLC |
Analogues de nucléoside 2'-dichloro et 2'-fluoro-2'-chloro analogues pour l'infection par le vhc
|
US10683321B2
(en)
|
2013-12-18 |
2020-06-16 |
Idenix Pharmaceuticals Llc |
4′-or nucleosides for the treatment of HCV
|
JPWO2015108047A1
(ja)
|
2014-01-15 |
2017-03-23 |
株式会社新日本科学 |
免疫誘導活性を有するキラル核酸アジュバンド及び免疫誘導活性剤
|
WO2015108048A1
(fr)
|
2014-01-15 |
2015-07-23 |
株式会社新日本科学 |
Adjuvant d'acide nucléique chiral ayant un effet antitumoral et agent antitumoral
|
US10322173B2
(en)
|
2014-01-15 |
2019-06-18 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent
|
SG10201912897UA
(en)
|
2014-01-16 |
2020-02-27 |
Wave Life Sciences Ltd |
Chiral design
|
CN114404427A
(zh)
|
2014-02-13 |
2022-04-29 |
配体药物公司 |
前药化合物及其用途
|
JP6452711B2
(ja)
|
2014-02-20 |
2019-01-16 |
グラクソスミスクライン、インテレクチュアル、プロパティー、(ナンバー2)、リミテッドGlaxosmithkline Intellectual Property (No.2) Limited |
ヒトインターフェロンの誘導物質としてのピロロ[3,2]ピリミジン誘導体
|
WO2015134561A1
(fr)
|
2014-03-05 |
2015-09-11 |
Idenix Pharmaceuticals, Inc. |
Compositions pharmaceutiques comprenant un inhibiteur de flaviviridae hétéroarylène fusionné en 5,5 et son utilisation pour le traitement ou la prévention d'une infection par les flaviviridae
|
US20170066779A1
(en)
|
2014-03-05 |
2017-03-09 |
Idenix Pharmaceuticals Llc |
Solid forms of a flaviviridae virus inhibitor compound and salts thereof
|
CA2943075C
(fr)
|
2014-03-19 |
2023-02-28 |
Infinity Pharmaceuticals, Inc. |
Composes heterocycliques destines a etre utilises dans le traitement de troubles medies par pi3k-gamma
|
US20150320755A1
(en)
|
2014-04-16 |
2015-11-12 |
Infinity Pharmaceuticals, Inc. |
Combination therapies
|
WO2015161137A1
(fr)
|
2014-04-16 |
2015-10-22 |
Idenix Pharmaceuticals, Inc. |
Nucléosides méthyle ou alcynyle substitués en position 3 pour le traitement du virus de l'hépatite c
|
CN106459133B
(zh)
*
|
2014-06-10 |
2019-12-06 |
安捷伦科技有限公司 |
用于“z核苷酸”的保护基团及其方法
|
EP3797782A1
(fr)
|
2014-06-24 |
2021-03-31 |
Janssen BioPharma, Inc. |
Nucléosides substitués, nucléotides et leurs analogues pour traiter les infections virales
|
CN106604734B
(zh)
|
2014-06-24 |
2021-08-13 |
艾丽奥斯生物制药有限公司 |
取代的核苷、核苷酸和其类似物
|
EP3164136A4
(fr)
|
2014-07-02 |
2018-04-04 |
Ligand Pharmaceuticals, Inc. |
Composés de promédicaments et leurs utilisations
|
WO2016054491A1
(fr)
|
2014-10-03 |
2016-04-07 |
Infinity Pharmaceuticals, Inc. |
Composés hétérocycliques et leurs utilisations
|
TWI698444B
(zh)
|
2014-10-29 |
2020-07-11 |
美商基利科學股份有限公司 |
製備核糖苷的方法
|
ES2917887T3
(es)
|
2014-11-13 |
2022-07-12 |
Glaxosmithkline Biologicals Sa |
Derivados de adenina que son útiles en el tratamiento de enfermedades alérgicas u otras afecciones inflamatorias
|
MA41213A
(fr)
|
2014-12-19 |
2017-10-24 |
Alios Biopharma Inc |
Nucléosides substitués, nucléotides et analogues de ceux-ci
|
MA41441A
(fr)
|
2014-12-19 |
2017-12-12 |
Alios Biopharma Inc |
Nucléosides substitués, nucléotides et analogues de ceux-ci
|
AU2016229966B2
(en)
|
2015-03-06 |
2018-09-27 |
Atea Pharmaceuticals, Inc. |
Beta-D-2'-deoxy-2'alpha-fluoro-2'-beta-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment
|
EP3303362B1
(fr)
|
2015-06-03 |
2022-10-19 |
Teva Pharmaceuticals International GmbH |
Procédés perfectionnés de préparation de sofosbuvir et d'intermédiaires de celui-ci
|
AU2016287585B2
(en)
|
2015-07-02 |
2020-12-17 |
Otsuka Pharmaceutical Co., Ltd. |
Lyophilized pharmaceutical compositions
|
BR112018002399A2
(pt)
|
2015-08-06 |
2018-09-25 |
Chimerix, Inc. |
nucleosídeos de pirrolopirimidina e análogos dos mesmos, úteis como agentes antivirais
|
BR112018002757A8
(pt)
|
2015-08-13 |
2023-04-11 |
Merck Sharp & Dohme |
Composto, composição farmacêutica, e, métodos para induzir uma resposta imune, para induzir uma produção de interferon tipo i e para tratamento de um distúrbio
|
US10160761B2
(en)
|
2015-09-14 |
2018-12-25 |
Infinity Pharmaceuticals, Inc. |
Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the same
|
PT3785717T
(pt)
|
2015-09-16 |
2022-04-14 |
Gilead Sciences Inc |
Métodos para o tratamento de infeções por coronaviridae
|
JP6768796B2
(ja)
*
|
2015-09-23 |
2020-10-14 |
メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. |
4’−置換ヌクレオシド逆転写酵素阻害剤及びその調製
|
WO2017093933A1
(fr)
|
2015-12-03 |
2017-06-08 |
Glaxosmithkline Intellectual Property Development Limited |
Dinucléotides cycliques de purine à titre de modulateurs du sting
|
WO2017156262A1
(fr)
|
2016-03-09 |
2017-09-14 |
Alios Biopharma, Inc. |
Antiviraux acycliques
|
US10759806B2
(en)
|
2016-03-17 |
2020-09-01 |
Infinity Pharmaceuticals, Inc. |
Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors
|
PT3433257T
(pt)
|
2016-03-24 |
2023-11-29 |
Novartis Ag |
Análogos nucleosídeos de alquinil como inibidores do rinovírus humano
|
EP3440072B1
(fr)
|
2016-04-07 |
2020-01-29 |
GlaxoSmithKline Intellectual Property Development Ltd |
Amides hétérocycliques utiles en tant que modulateurs de protéine
|
CN109608443B
(zh)
|
2016-04-07 |
2021-09-07 |
葛兰素史密斯克莱知识产权发展有限公司 |
用作蛋白质调节剂的杂环酰胺
|
CA3022119A1
(fr)
|
2016-04-28 |
2017-11-02 |
Emory University |
Compositions therapeutiques a base de nucleotides et nucleosides contenant un alcyne et utilisations associees
|
WO2017214269A1
(fr)
|
2016-06-08 |
2017-12-14 |
Infinity Pharmaceuticals, Inc. |
Composés hétérocycliques et leurs utilisations
|
SG11201811237WA
(en)
|
2016-06-24 |
2019-01-30 |
Infinity Pharmaceuticals Inc |
Combination therapies
|
US10202412B2
(en)
|
2016-07-08 |
2019-02-12 |
Atea Pharmaceuticals, Inc. |
β-D-2′-deoxy-2′-substituted-4′-substituted-2-substituted-N6-substituted-6-aminopurinenucleotides for the treatment of paramyxovirus and orthomyxovirus infections
|
US10711029B2
(en)
|
2016-07-14 |
2020-07-14 |
Atea Pharmaceuticals, Inc. |
Beta-d-2′-deoxy-2′-alpha-fluoro-2′-beta-c-substituted-4′fluoro-n6-substituted-6-amino-2-substituted purine nucleotides for the treatment of hepatitis c virus infection
|
WO2018031818A2
(fr)
*
|
2016-08-12 |
2018-02-15 |
Alios Biopharma, Inc. |
Nucléosides substitués, nucléotides et analogues de ceux-ci
|
ES2907874T3
(es)
|
2016-09-07 |
2022-04-26 |
Atea Pharmaceuticals Inc |
Nucleótidos de purina 2'-sustituidos-N6-sustituidos para el tratamiento de virus de ARN
|
WO2018089306A1
(fr)
*
|
2016-11-10 |
2018-05-17 |
Oyagen, Inc. |
Méthodes de traitement et d'inhibition d'une infection par le virus ebola
|
EP4035659A1
(fr)
|
2016-11-29 |
2022-08-03 |
PureTech LYT, Inc. |
Exosomes destinés à l'administration d'agents thérapeutiques
|
WO2018110643A1
(fr)
*
|
2016-12-14 |
2018-06-21 |
ヤマサ醤油株式会社 |
Dérivé de nucléoside présentant une activité antivirale
|
CN115477679A
(zh)
|
2017-02-01 |
2022-12-16 |
阿堤亚制药公司 |
用于治疗丙型肝炎病毒的核苷酸半硫酸盐
|
CN116036112A
(zh)
|
2017-03-14 |
2023-05-02 |
吉利德科学公司 |
治疗猫冠状病毒感染的方法
|
JP2020518578A
(ja)
|
2017-05-01 |
2020-06-25 |
ギリアード サイエンシーズ, インコーポレイテッド |
(S)−2−エチルブチル2−(((S)−(((2R,3S,4R,5R)−5−(4−アミノピロロ[2,1−f][1,2,4]トリアジン−7−イル)−5−シアノ−3,4−ジヒドロキシテトラヒドロフラン−2−イル)メトキシ)(フェノキシ)ホスホリル)アミノ)プロパノエートの結晶形態
|
TW201919648A
(zh)
|
2017-07-11 |
2019-06-01 |
美商基利科學股份有限公司 |
用於治療病毒感染之含rna聚合酶抑制劑與環糊精的組合物
|
SI3661937T1
(sl)
|
2017-08-01 |
2021-11-30 |
Gilead Sciences, Inc. |
Kristalinične oblike etil((S)-((((2R,5R)-5-(6-amino-9H-purin-9-IL)-4- fluoro-2,5-dihidrofuran-2-IL)oksi)metil)(fenoksi)fosforil)-L-alaninata (GS-9131) za zdravljenje virusnih okužb
|
JP2020529409A
(ja)
|
2017-08-03 |
2020-10-08 |
大塚製薬株式会社 |
薬物化合物およびその精製方法
|
JP2020534361A
(ja)
|
2017-09-18 |
2020-11-26 |
ヤンセン・バイオファーマ・インコーポレイテッド |
置換ヌクレオシド、ヌクレオチド、及びそのアナログ
|
WO2019060692A1
(fr)
|
2017-09-21 |
2019-03-28 |
Chimerix, Inc. |
Formes morphiques de 4-amino-7-(3,4-dihydroxy-5-(hydroxyméthyle)tétrahydrofurane-2-yl)-2-méthyle-7 h-pyrrolo[2,3-d]pyrimidine-5-carboxamide et leurs utilisations
|
TW201927771A
(zh)
|
2017-10-05 |
2019-07-16 |
英商葛蘭素史密斯克藍智慧財產發展有限公司 |
可作為蛋白質調節劑之雜環醯胺及其使用方法
|
BR112020006780A2
(pt)
|
2017-10-05 |
2020-10-06 |
Glaxosmithkline Intellectual Property Development Limited |
moduladores do estimulador de genes do interferon (sting)
|
EP3737676B1
(fr)
|
2018-01-09 |
2024-03-06 |
Ligand Pharmaceuticals, Inc. |
Composés acétal et leurs utilisations thérapeutiques
|
JP7417529B2
(ja)
|
2018-03-07 |
2024-01-18 |
サノフイ |
ヌクレオチド前駆体、ヌクレオチド類似体およびこれを含むオリゴマー化合物
|
JP2021521118A
(ja)
|
2018-04-10 |
2021-08-26 |
アテア ファーマシューティカルズ, インコーポレイテッド |
肝硬変を伴うhcv感染患者の治療
|
MX2020010667A
(es)
|
2018-04-12 |
2021-01-08 |
Modis Therapeutics Inc |
Profarmacos de desoxinucleosidos para el tratamiento de enfermedades causadas por reservas desequilibradas de nucleotidos.
|
GB201807924D0
(en)
|
2018-05-16 |
2018-06-27 |
Ctxt Pty Ltd |
Compounds
|
KR20210102360A
(ko)
|
2018-12-12 |
2021-08-19 |
얀센 바이오파마, 인코퍼레이트. |
항바이러스제로서의 사이클로부틸 뉴클레오시드 유사체
|
CA3122410A1
(fr)
|
2018-12-12 |
2020-06-18 |
Janssen Biopharma, Inc. |
Analogues de nucleoside cyclopentyle utilises comme antiviraux
|
JP2022533194A
(ja)
|
2019-05-16 |
2022-07-21 |
スティングセラ インコーポレイテッド |
ベンゾ[b][1,8]ナフチリジン酢酸誘導体および使用方法
|
JP2022533390A
(ja)
|
2019-05-16 |
2022-07-22 |
スティングセラ インコーポレイテッド |
オキソアクリジニル酢酸誘導体および使用方法
|
GB201910304D0
(en)
|
2019-07-18 |
2019-09-04 |
Ctxt Pty Ltd |
Compounds
|
GB201910305D0
(en)
|
2019-07-18 |
2019-09-04 |
Ctxt Pty Ltd |
Compounds
|
EP4025582A1
(fr)
|
2019-09-05 |
2022-07-13 |
Sanofi |
Oligonucléotides contenant des analogues nucléotidiques
|
US11660307B2
(en)
|
2020-01-27 |
2023-05-30 |
Gilead Sciences, Inc. |
Methods for treating SARS CoV-2 infections
|
WO2021158248A1
(fr)
|
2020-02-04 |
2021-08-12 |
Oyagen, Inc. |
Méthodes de traitement d'infections à coronavirus
|
US10874687B1
(en)
|
2020-02-27 |
2020-12-29 |
Atea Pharmaceuticals, Inc. |
Highly active compounds against COVID-19
|
AU2021234308C1
(en)
|
2020-03-12 |
2024-02-22 |
Gilead Sciences, Inc. |
Methods of preparing 1'-cyano nucleosides
|
JP7482250B2
(ja)
|
2020-04-06 |
2024-05-13 |
ギリアード サイエンシーズ, インコーポレイテッド |
1’-シアノ置換カルバヌクレオシド類似体の吸入製剤
|
CN115666570A
(zh)
|
2020-05-29 |
2023-01-31 |
吉利德科学公司 |
瑞德西韦治疗方法
|
EP4172160A2
(fr)
|
2020-06-24 |
2023-05-03 |
Gilead Sciences, Inc. |
Analogues de 1'-cyano nucléoside et leurs utilisations
|
PT4204421T
(pt)
|
2020-08-27 |
2024-06-25 |
Gilead Sciences Inc |
Compostos e métodos para o tratamento de infeções virais
|
CN116368146A
(zh)
|
2020-10-20 |
2023-06-30 |
赛诺菲 |
脱唾液酸糖蛋白受体的新型配体
|
CN112979735B
(zh)
*
|
2021-04-25 |
2021-09-17 |
南京颐媛生物医学研究院有限公司 |
抗肝炎病毒的化合物及其制备方法和应用
|
CN113278041B
(zh)
*
|
2021-07-16 |
2021-10-19 |
南京颐媛生物医学研究院有限公司 |
一种核苷磷酸酯及其合成方法与抗肝炎病毒的制药应用
|
EP4320128A1
(fr)
|
2022-03-02 |
2024-02-14 |
Gilead Sciences, Inc. |
Composés et méthodes pour traiter des infections virales
|
CN115651047B
(zh)
*
|
2022-11-14 |
2023-03-17 |
天津奥瑞芙生物医药有限公司 |
2’-o-甲基核苷的制备方法
|
CN117362369B
(zh)
*
|
2023-10-09 |
2024-04-19 |
长沙晨辰医药科技有限公司 |
一锅法合成核苷二磷酸
|